HK Stock Market Move | CREALITY (03388) rises over 6% as the company continues to advance its new product lineup, with the industry maintaining relatively high prosperity.
CREALITY (03388) rose over 6%, up 6.56% as of press time, at HK$25.98, with a turnover of HK$56.4937 million.
CREALITY (03388) rose over 6%, up 6.56% as of press time, at HK$25.98, with a turnover of HK$56.4937 million.
On the news front, at the IFA 2026 exhibition held from September 4 to 8, CREALITY showcased the SPARKX i8 for the first time, with a focus on presenting the upcoming flagship model K3, as consumer-grade 3D printing extends toward multi-color, multi-material, and AI-empowered directions. Notably, on September 7, CREALITY was officially included as a constituent of the Hang Seng Composite Index, simultaneously meeting the criteria for inclusion in the Stock Connect, taking less than half a year from listing to Stock Connect inclusion.
A previous research report by Sinolink pointed out that in the second half of the year, the K3 series (equipped with KliTek multi-nozzle technology), the i8 four-color printer, and a children's dedicated printer will be launched successively. The K3 series, leveraging KliTek multi-nozzle technology, is expected to achieve an independent differentiated technology path in the field of high-speed multi-color multi-material printing, achieving a leap in product and brand strength. Sealand believes that the industry maintains relatively high prosperity, and future new products and channel expansion will continue to drive the industry forward.
Related Articles

SAM WOO CONS (03822) awarded construction engineering contract

Shandong Lukang Pharmaceutical (600789.SH) subsidiary obtains drug registration certificate for Sacubitril Valsartan Sodium Tablets.

HSBC HOLDINGS (00005) spent HKD 93.2413 million to repurchase 580,000 shares on September 21.
SAM WOO CONS (03822) awarded construction engineering contract

Shandong Lukang Pharmaceutical (600789.SH) subsidiary obtains drug registration certificate for Sacubitril Valsartan Sodium Tablets.

HSBC HOLDINGS (00005) spent HKD 93.2413 million to repurchase 580,000 shares on September 21.






